David H Farrell1, Elizabeth A Rick2, Elizabeth N Dewey2, Martin A Schreiber2, Susan E Rowell3. 1. Division of Trauma, Critical Care and Acute Care Surgery, Department of Surgery, Oregon Health & Science University, Portland, OR, USA. Electronic address: farrelld@ohsu.edu. 2. Division of Trauma, Critical Care and Acute Care Surgery, Department of Surgery, Oregon Health & Science University, Portland, OR, USA. 3. Division of Trauma, Critical Care and Acute Care Surgery, Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
Abstract
BACKGROUND: γ' fibrinogen is an alternatively-spliced fibrinogen variant that displays different coagulation parameters in vitro than the major form of fibrinogen. Purified γ' fibrinogen has slower clotting kinetics than unfractionated fibrinogen, but forms clots that are stronger and resistant to fibrinolysis. However, these properties have only been investigated in human populations in a limited number of studies. We therefore performed a retrospective analysis to test the hypothesis that γ' fibrinogen levels influence coagulation in vivo. METHODS: In the present study, we utilized blood samples that were collected from traumatic brain injury patients to probe the relationship between γ' fibrinogen levels and traditional coagulation parameters. RESULTS: The results show that the levels of γ' fibrinogen were inversely associated with clotting kinetics, indicated by a shortened INR. In addition, the levels of γ' fibrinogen were associated with stronger clots by thrombelastography. However, these changes were not associated with significant changes in hemorrhage progression. CONCLUSIONS: These findings verify that γ' fibrinogen properties observed in purified systems result in similar properties in a clinical setting, and may affect coagulation.
BACKGROUND: γ' fibrinogen is an alternatively-spliced fibrinogen variant that displays different coagulation parameters in vitro than the major form of fibrinogen. Purified γ' fibrinogen has slower clotting kinetics than unfractionated fibrinogen, but forms clots that are stronger and resistant to fibrinolysis. However, these properties have only been investigated in human populations in a limited number of studies. We therefore performed a retrospective analysis to test the hypothesis that γ' fibrinogen levels influence coagulation in vivo. METHODS: In the present study, we utilized blood samples that were collected from traumatic brain injurypatients to probe the relationship between γ' fibrinogen levels and traditional coagulation parameters. RESULTS: The results show that the levels of γ' fibrinogen were inversely associated with clotting kinetics, indicated by a shortened INR. In addition, the levels of γ' fibrinogen were associated with stronger clots by thrombelastography. However, these changes were not associated with significant changes in hemorrhage progression. CONCLUSIONS: These findings verify that γ' fibrinogen properties observed in purified systems result in similar properties in a clinical setting, and may affect coagulation.
Authors: Rehana S Lovely; Steven C Kazmierczak; Joseph M Massaro; Ralph B D'Agostino; Christopher J O'Donnell; David H Farrell Journal: Clin Chem Date: 2010-03-26 Impact factor: 8.327
Authors: Shirley Uitte de Willige; Marieke C H de Visser; Jeanine J Houwing-Duistermaat; Frits R Rosendaal; Hans L Vos; Rogier M Bertina Journal: Blood Date: 2005-09-06 Impact factor: 22.113
Authors: Evita G van den Herik; Elim Y L Cheung; Lonneke M L de Lau; Heleen M den Hertog; Frank W Leebeek; Diederik W J Dippel; Peter J Koudstaal; Moniek P M de Maat Journal: Thromb Haemost Date: 2010-12-06 Impact factor: 5.249
Authors: Jasper H Smalberg; Edith Koehler; Sarwa Darwish Murad; Aurelie Plessier; Susana Seijo; Jonel Trebicka; Massimo Primignani; Dingeman C Rijken; Moniek P M de Maat; Juan-Carlos García-Pagán; Dominique C Valla; Harry L A Janssen; Frank W G Leebeek Journal: Thromb Haemost Date: 2013-01-10 Impact factor: 5.249
Authors: Kelly A Fair; David H Farrell; Belinda H McCully; Elizabeth A Rick; Elizabeth N Dewey; Cole Hilliard; Rondi Dean; Amber Lin; Holly Hinson; Ronald Barbosa; Martin A Schreiber; Susan E Rowell Journal: J Neurotrauma Date: 2021-04-15 Impact factor: 5.269